340 related articles for article (PubMed ID: 24827495)
1. Thrombolytic therapy for stroke in patients with preexisting cognitive impairment.
Murao K; Leys D; Jacquin A; Kitazono T; Bordet R; Béjot Y; Kimura K; Godefroy O; Wakisaka Y; Moulin S; Ago T; Sibon I; Bombois S; Mas JL; Hénon H; Pasquier F; Giroud M; Cordonnier C; Okada Y;
Neurology; 2014 Jun; 82(23):2048-54. PubMed ID: 24827495
[TBL] [Abstract][Full Text] [Related]
2. Proportion of single-chain recombinant tissue plasminogen activator and outcome after stroke.
Leys D; Hommet Y; Jacquet C; Moulin S; Sibon I; Mas JL; Moulin T; Giroud M; Sagnier S; Cordonnier C; Medeiros de Bustos E; Turc G; Ronzière T; Bejot Y; Detante O; Ouk T; Mendyk AM; Favrole P; Zuber M; Triquenot-Bagan A; Ozkul-Wermester O; Montoro FM; Lamy C; Faivre A; Lebouvier L; Potey C; Poli M; Hénon H; Renou P; Dequatre-Ponchelle N; Bodenant M; Debruxelles S; Rossi C; Bordet R; Vivien D;
Neurology; 2016 Dec; 87(23):2416-2426. PubMed ID: 27815401
[TBL] [Abstract][Full Text] [Related]
3. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
4. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
Al-Khaled M; Matthis C; Eggers J
J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
[TBL] [Abstract][Full Text] [Related]
5. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR.
Toni D; Ahmed N; Anzini A; Lorenzano S; Brozman M; Kaste M; Mikulik R; Putaala J; Wahlgren N;
Neurology; 2012 Mar; 78(12):880-7. PubMed ID: 22402853
[TBL] [Abstract][Full Text] [Related]
6. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.
Romano JG; Smith EE; Liang L; Gardener H; Camp S; Shuey L; Cook A; Campo-Bustillo I; Khatri P; Bhatt DL; Fonarow GC; Sacco RL; Schwamm LH
JAMA Neurol; 2015 Apr; 72(4):423-31. PubMed ID: 25642650
[TBL] [Abstract][Full Text] [Related]
8. Safety of off-label stroke treatment with tissue plasminogen activator.
Kvistad CE; Logallo N; Thomassen L; Waje-Andreassen U; Brøgger J; Naess H
Acta Neurol Scand; 2013 Jul; 128(1):48-53. PubMed ID: 23311439
[TBL] [Abstract][Full Text] [Related]
9. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
[TBL] [Abstract][Full Text] [Related]
10. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
[TBL] [Abstract][Full Text] [Related]
11. Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants.
Matute MC; Masjuan J; Egido JA; Fuentes B; Simal P; Díaz-Otero F; Reig G; Díez-Tejedor E; Gil-Nuñez A; Vivancos J; Alonso de Leciñana M
Cerebrovasc Dis; 2012; 33(3):231-9. PubMed ID: 22261670
[TBL] [Abstract][Full Text] [Related]
12. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
13. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study.
Paciaroni M; Agnelli G; Caso V; Pieroni A; Bovi P; Cappellari M; Zini A; Nichelli P; Inzitari D; Nesi M; Nencini P; Pezzini A; Padovani A; Tassinari T; Orlandi G; Chiti A; Gialdini G; Alberti A; Venti M; Acciarresi M; D'Amore C; Luda E; Tassi R; Martini G; Ferrarese C; Beretta S; Trentini C; Silvestrelli G; Lanari A; Previdi P; Ciccone A; Delodovici ML; Bono G; Galletti G; Marcheselli S; Del Sette M; Traverso E; Riva M; Silvestrini M; Cerqua R; Consoli D; Monaco S; Toni D
Cerebrovasc Dis; 2012; 34(5-6):430-5. PubMed ID: 23207482
[TBL] [Abstract][Full Text] [Related]
14. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
Seet RC; Rabinstein AA
Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
[TBL] [Abstract][Full Text] [Related]
15. Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin.
Mazya MV; Lees KR; Markus R; Roine RO; Seet RC; Wahlgren N; Ahmed N;
Ann Neurol; 2013 Aug; 74(2):266-74. PubMed ID: 23744571
[TBL] [Abstract][Full Text] [Related]
16. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
Hassan AE; Chaudhry SA; Jani V; Grigoryan M; Khan AA; Adil MM; Qureshi AI
J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555
[TBL] [Abstract][Full Text] [Related]
17. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
Vaishnav AG; Pettigrew LC; Ryan S
Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Age and Sex on Clinical Outcome after Intravenous Recombinant Tissue Plasminogen Activator Treatment in Patients with Acute Ischemic Stroke.
Buijs JE; Uyttenboogaart M; Brouns R; de Keyser J; Kamphuisen PW; Luijckx GJ
J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):312-6. PubMed ID: 26527412
[TBL] [Abstract][Full Text] [Related]
19. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
[TBL] [Abstract][Full Text] [Related]
20. Validation assessment of risk tools to predict outcome after thrombolytic therapy for acute ischemic stroke.
Van Hooff RJ; Nieboer K; De Smedt A; Moens M; De Deyn PP; De Keyser J; Brouns R
Clin Neurol Neurosurg; 2014 Oct; 125():189-93. PubMed ID: 25171393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]